News
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...
Q2 2025 Earnings Call Transcript August 13, 2025 ARS Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback